MOTS-C
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA.
- Vial Size
- 40mg
- Molecular Weight
- 2174.59 g/mol
- Half-life
- Tissue-dependent
- Latest Lot Purity
- 99.67%
Mechanism of Action
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA. Research interest centers on its modulation of AMPK signalling, metabolic flexibility, and insulin sensitivity in cellular models.
Research Context
- Mitochondrial metabolism research
- AMPK pathway studies
- Insulin sensitivity models
- Cellular resilience and longevity research
Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
Lot NX-034 · Verified at 99.67%
Plasma Profile & Protocol
Modelled plasma concentration over time, reconstitution calculator, and a literature-derived research protocol for MOTS-C.
Illustrative Bateman model derived from published half-life and absorption data. For research-context visualisation only.
Solve for syringe units assuming a U-100 insulin syringe. Defaults seeded from the MOTS-C monograph.
U-100 insulin syringe assumed (100 units = 1 mL). For research dosing visualisation only. Verify all dilutions independently.
- Typical Dose
- 5–10 mg
- Frequency
- 2–3× weekly
- Cycle Length
- 4–6 weeks
- Route
- Subcutaneous
Note ·Mitochondrial-derived peptide; AMPK pathway research.
Related Compounds
All compounds →
GHK-Cu
Copper tripeptide with strong regenerative and dermal research utility.
NAD+
Mitochondrial coenzyme for longevity, energy, and recovery research.
For Research Use Only · This monograph summarises publicly available research literature for educational, in-vitro and laboratory research purposes only. Nexora Labs products are not drugs, food, supplements, or cosmetics, and are not intended to diagnose, treat, cure or prevent any condition.